4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-055360
SVP & Chief Financial Officer sold 120,000 shares at $24.45 ($2,934,000)
- SVP & Chief Financial Officer acquired 120,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP & Chief Financial Officer | 2017-10-02 | Option exercise | +120,000 | $11.34 | $1,360,800 | 183,414 | D: show line 1 in the form |
| Labrucherie Gil M SVP & Chief Financial Officer | 2017-10-02 | Sale | −120,000 | $24.45 | $2,934,000 | 63,414 | D: show line 2 in the form |
| Open-market sales · 120,000 sh · avg $24.45 · $2,934,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP & Chief Financial Officer | 2017-10-02 | Option exercise · Stock Option | −120,000 | 0 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…